JNJ

Johnson & Johnson Stock Analysis

NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

$228.39

▼ -2.48%

Latest quote · typically 15 min delayed

$231.78

Open

$232.75

High

$227.60

Low

$234.20

Prev close

$549.78B

Market cap

Guests get 2 analyses/day. .

What you get with ImpliedLens

📊

Financial statements

Income, balance sheet, cash flow from SEC filings with 30+ calculated ratios.

🧮

DCF valuation

Customizable discounted cash flow model with live inputs.

🎯

Analyst targets

Price targets, recommendation breakdowns, earnings surprises.

🏦

Institutional context

Ownership data and aggregated FINRA OTC activity.

📋

SEC filings

Direct links to 10-K, 10-Q, 8-K, and proxy statements.

📈

Projection models

Bull/base/bear scenario modeling with editable assumptions.

01Which products and pipeline milestones drive Johnson & Johnson's next five years of cash flow?

02Which risks would invalidate the investment thesis for JNJ?

03How does JNJ's valuation compare with its growth, quality, and closest alternatives?